Contract notice
Section I: Contracting
authority
I.1) Name and addresses
University Hospitals Plymouth
Derriford Road
Plymouth
PL6 8DH
UK
Contact person: Pippa Farr
Telephone: +44 7379141462
E-mail: pippa.farr@nhs.net
NUTS: UKK41
Internet address(es)
Main address: https://www.plymouthhospitals.nhs.uk/
Address of the buyer profile: https://www.plymouthhospitals.nhs.uk/
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://health-family.force.com/s/Welcome
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://health-family.force.com/s/Welcome
Tenders or requests to participate must be sent to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://health-family.force.com/s/Welcome
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Tender for the provision of Aseptic Isolator systems and associated services
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Tender for the provision of Aseptic Isolator systems and associated services
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKK41
II.2.4) Description of the procurement
A new Pharmacy Aseptic Unit (PAU) building will be located at the Estover site of UHP. The facility will be a stand-alone new build on an existing plot built between the warehouse and staff car park. This PAU shall provide a facility suitable to be licensed by the Medicines and Healthcare Product Regulatory Agency (MHRA) for the processing and production of aseptically prepared products for the Trust and external customers, in particular cancer chemotherapy treatment preparation (cytotoxic), but also a range of general intravenous preparations (IV) and Parenteral Nutrition (PN). Additionally, new gene therapy products that will require its own dedicated and segregated suite. This tender is for the requirements for the supply, installation, commissioning, and validation and maintenance of three new negative pressure and two new positive pressure isolator systems, that will comply with the current Good Manufacturing Practice (GMP) requirements as described by the Medicines and Healthcare Products Regulatory Agency (MHRA).
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
3 000 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start:
31/10/2024
End:
09/01/2036
This contract is subject to renewal: Yes
Description of renewals:
The design, prototype and manufacturing is proposed to commence 31/10/2024, with supply from 10/01/2026 the contract will then run for 7 years with an option to extend for up to a further 3 years to 2036.
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
III.2.3) Information about staff responsible for the performance of the contract
Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
20/09/2024
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Tender must be valid until:
31/12/2024
IV.2.7) Conditions for opening of tenders
Date:
03/10/2024
Local time: 12:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.4) Procedures for review
VI.4.1) Review body
University Hospitals Plymouth NHS Trust
Brittany House
Derriford Plymouth
PL6 5DZ
UK
E-mail: pippa.farr@nhs.net
Internet address(es)
URL: https://www.plymouthhospitals.nhs.uk
VI.5) Date of dispatch of this notice
30/08/2024